Shoulder Innovations, Inc.
- SI · NYSE
- Surgical & Medical Instruments & Apparatus
- Grand Rapids, MI
- 75 employees
- CIK 0001699350
Updated from SEC filings through
Top things to know
Executives
- Robert Joseph Ball CEO & Executive Chairman 4, 2026-09-14
- Jeffrey S. Points Chief Financial Officer 4, 2026-03-17
- Jeffrey Points Chief Financial Officer 10-K, 2026-03-10
- Matthew Fraser Ahearn Chief Operating Officer 4, 2026-08-18
- Jonathan E. Osborne Chief Commercial Officer 3, 2026-08-10
- Matthew Ahearn Chief Operating Officer 10-K, 2026-03-10
What leadership is saying
“Our third quarter results reflect the consistency of our commercial model, as we added new surgeons ahead of plan, grew volume within our existing customer base, and kept our product roadmap moving”
Earnings press release (8-K Ex. 99.1), filed November 5, 2026
Shoulder Innovations, Inc. is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Grand Rapids, MI. It trades as SI on NYSE. Revenue was $47.3M in the fiscal year ending December 31, 2025, +49.6% from the year before. It reported about 75 employees. Robert Joseph Ball is CEO & Executive Chairman.
Five-year financials
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $47.3M 10-K, 2026-03-10 | $31.6M 10-K, 2026-03-10 |
| Operating income | -$26.3M 10-K, 2026-03-10 | -$14.7M 10-K, 2026-03-10 |
| SG&A | $54.8M 10-K, 2026-03-10 | $34.5M 10-K, 2026-03-10 |
| Net income | -$40.4M 10-K, 2026-03-10 | -$15.6M 10-K, 2026-03-10 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Robert Joseph Ball Chief Executive Officer at Shoulder Innovations | CEO & Executive Chairman | 4, 2026-09-14 |
| Jeffrey S. Points Public Company CFO (NYSE: SI) / Strategic Financial Leadership / Life Science Expertise/ Board Member | Chief Financial Officer | 4, 2026-03-17 |
| Jeffrey Points | Chief Financial Officer | 10-K, 2026-03-10 |
| Matthew Fraser Ahearn | Chief Operating Officer | 4, 2026-08-18 |
| Jonathan E. Osborne | Chief Commercial Officer | 3, 2026-08-10 |
| David L. Blue | Named in proxy bio: Chief Customer Experience Officer | DEF 14A, 2026-04-29 |
| Matthew Ahearn | Chief Operating Officer | 10-K, 2026-03-10 |
| David Blue | Chief Customer Experience Officer | 10-K, 2026-03-10 |
| Jon Osborne | Senior Vice President of Commercial Development | 10-K, 2026-03-10 |
| Andrew Hykes | Board member (per proxy) bio: member of our Board | DEF 14A, 2026-04-29 |
| Paul Buckman | Board member (per proxy) bio: Lead Independent Director | DEF 14A, 2026-04-29 |
| Richard J. Buchholz | Board member (per proxy) bio: member of our Board | DEF 14A, 2026-04-29 |
What Shoulder Innovations, Inc. does
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Our ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 20.9 million (as of October 29, 2026) | 10-Q, November 5, 2026 |
|---|---|---|
| Public float | $0 (as of June 30, 2025) | 10-K, March 10, 2026 |
| Reportable segments | 1 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting June 26, 2026 (filed April 29, 2026) | DEF 14A, April 29, 2026 |
| Auditor | Deloitte & Touche LLP (Grand Rapids, Michigan) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| September 14, 2026 | Robert Joseph Ball CEO & Executive Chairman | Sale | 10,175 | $188K | Form 4, September 14, 2026 |
| August 18, 2026 | Matthew Fraser Ahearn Chief Operating Officer | Sale | 22,500 | $465K | Form 4, August 18, 2026 |
| June 15, 2026 | Matthew Fraser Ahearn Chief Operating Officer | Sale | 20,000 | $374K | Form 4, June 16, 2026 |
| March 13, 2026 | Robert Joseph Ball CEO & Executive Chairman | Buy | 2,200 | $33K | Form 4, March 17, 2026 |
| March 13, 2026 | Richard Buchholz Director | Buy | 1,000 | $15K | Form 4, March 17, 2026 |
| March 13, 2026 | Jeffrey S. Points Chief Financial Officer | Buy | 2,000 | $30K | Form 4, March 17, 2026 |
| December 12, 2025 | Jeffrey S. Points Chief Financial Officer | Buy | 2,000 | $30K | Form 4, December 15, 2025 |
| December 12, 2025 | Robert Joseph Ball CEO & Executive Chairman | Buy | 7,200 | $107K | Form 4, December 15, 2025 |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-08
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-10
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-29
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-26
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-13
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-04-27
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-04-14
- Item 1.01 Entry into a material definitive agreement
- 8-K filed 2026-03-10
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 5.02 Departure or appointment of directors or officers; compensation
Frequently asked questions about Shoulder Innovations, Inc.
- What does Shoulder Innovations, Inc. do?
- Shoulder Innovations, Inc. is classified by the SEC as Surgical & Medical Instruments & Apparatus (SIC 3841). It is based in Grand Rapids, MI.
- What is Shoulder Innovations, Inc.'s revenue?
- $47.3M for the fiscal year ending December 31, 2025, from its 10-K filed March 10, 2026.
- Is Shoulder Innovations, Inc. profitable?
- Shoulder Innovations, Inc. reported net income of -$40.4M for the fiscal year ending December 31, 2025.
- How many employees does Shoulder Innovations, Inc. have?
- About 75 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Shoulder Innovations, Inc.?
- Robert Joseph Ball, CEO & Executive Chairman, as named in a 4 filed September 14, 2026.
- Who is the CFO of Shoulder Innovations, Inc.?
- Jeffrey S. Points, Chief Financial Officer, as named in a 4 filed March 17, 2026.
- Where is Shoulder Innovations, Inc. headquartered?
- Grand Rapids, MI.
- What is Shoulder Innovations, Inc.'s stock ticker?
- SI on NYSE.
- What industry is Shoulder Innovations, Inc. in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is Shoulder Innovations, Inc.'s website?
- shoulderinnovations.com.
- When does Shoulder Innovations, Inc. report earnings next?
- November 10, 2026. Source: pg_earnings_events.
- Is Shoulder Innovations, Inc. a public company?
- Yes. Shoulder Innovations, Inc. files with the SEC under CIK 0001699350 and trades as SI.
- Who audits Shoulder Innovations, Inc.?
- Deloitte & Touche LLP, Grand Rapids, Michigan, as named in its latest annual report (10-K).
- How many shares of Shoulder Innovations, Inc. are outstanding?
- 20.9 million shares as of October 29, 2026, from its 10-Q filed November 5, 2026.
- What is Shoulder Innovations, Inc.'s public float?
- $0 as of June 30, 2025, as reported on the cover of its 10-K filed March 10, 2026.
- How many business segments does Shoulder Innovations, Inc. report?
- 1 reportable segment for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is Shoulder Innovations, Inc.'s annual shareholder meeting?
- June 26, 2026, per its proxy statement (DEF 14A) filed April 29, 2026.
- Have Shoulder Innovations, Inc. insiders traded stock recently?
- Since August 1, 2025, officers and directors reported 3 open-market sales worth about $1.0M and 12 purchases worth about $6.5M on Forms 4 and 5. The most recent: Robert Joseph Ball (CEO & Executive Chairman) sold 10,175 shares on September 14, 2026.